In NASH patients, the activation of B cells leads to elevated expression of major histocompatibility complex II, and their migration to the liver precedes the recruitment of CD4+ and CD8+ T cells. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.